These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26502013)

  • 1. Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report.
    Rubinstein M; Assal A; Scherba M; Elman J; White R; Verma A; Strakhan M; Mohammadi F; Janakiram M
    Am J Hematol; 2016 Feb; 91(2):E1. PubMed ID: 26502013
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide.
    Li X; Hong Y; An Q; Chen J; Wei H; Chen HD; Gao XH
    JAMA Dermatol; 2013 Aug; 149(8):992-3. PubMed ID: 23783880
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosai-Dorfman disease successfully treated with thalidomide: A case report.
    Shahidi-Dadras M; Hamedani B; Niknezhad N; Ghilizadeh N
    Dermatol Ther; 2019 Sep; 32(5):e13005. PubMed ID: 31228316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosai-Dorfman disease: three difficult-to-diagnose cases.
    Du J; Ding X; Cai L; Sun P; Zhou C; Zhang J
    Eur J Dermatol; 2010; 20(5):650-1. PubMed ID: 20621850
    [No Abstract]   [Full Text] [Related]  

  • 5. Dermatoscopic findings in cutaneous Rosai-Dorfman disease and response to low-dose thalidomide.
    Wang F; Zhou H; Luo DQ; Han JD; Chen MK
    J Dtsch Dermatol Ges; 2014 Apr; 12(4):350-2. PubMed ID: 24580965
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab treatment in a child with rosai-dorfman disease and systemic lupus erythematosus.
    Alqanatish JT; Houghton K; Bond M; Senger C; Tucker LB
    J Rheumatol; 2010 Aug; 37(8):1783-4. PubMed ID: 20675857
    [No Abstract]   [Full Text] [Related]  

  • 7. An unusual case of multiple cutaneous Rosai-Dorfman disease involving two separate parts of the body.
    Jia J; Tian Q; Zhang H; Zheng Y
    Int J Dermatol; 2017 May; 56(5):576-578. PubMed ID: 28255989
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosai-Dorfman disease presenting as mediastinal lymphadenopathy: case report and review of the literature.
    Cobanoglu N; Galip N; Dalkan C; Comunoglu C; Bahceciler N
    Paediatr Int Child Health; 2013 May; 33(2):120-3. PubMed ID: 23925289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long term survival in a patient with aggressive Rosai-Dorfman disease treated with interferon alpha].
    Palomera L; M Domingo J; Soria J; Gutiérrez M
    Med Clin (Barc); 2001 Jun; 116(20):797-8. PubMed ID: 11440688
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment.
    Tjiu JW; Hsiao CH; Tsai TF
    Br J Dermatol; 2003 May; 148(5):1060-1. PubMed ID: 12786846
    [No Abstract]   [Full Text] [Related]  

  • 11. A case report demonstrating potential utility of topical imiquimod for cutaneous Rosai-Dorfman disease.
    Karadag AS; Tekin B; Hurdogan O; Dagdelen D; Dogan O; Buyukbabani N
    Dermatol Ther; 2019 Jan; 32(1):e12759. PubMed ID: 30288863
    [No Abstract]   [Full Text] [Related]  

  • 12. Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease.
    Hoyo-Muñoz A; Collado-Borrell R; Escudero-Vilaplana V; Bastos-Oreiro M; Herranz-Alonso A; Sanjurjo-Sáez M
    J Clin Pharm Ther; 2022 Apr; 47(4):548-551. PubMed ID: 34514634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma.
    Lee MJ; Wickner P; Fanning L; Schlossman R; Richardson P; Laubach J; Castells M
    Br J Haematol; 2014 Oct; 167(1):127-31. PubMed ID: 24824093
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of multisystemic Rosai-Dorfman disease with lenalidomide and dexamethasone: a case report.
    Liu T; Cao X
    Ann Hematol; 2022 Jun; 101(6):1351-1353. PubMed ID: 34741628
    [No Abstract]   [Full Text] [Related]  

  • 15. Rosai Dorfman disease.
    Mazhar E; Rahman N; Qureshi H; Bahar F; Zakai A; Rahman A; Hashmi KZ
    J Coll Physicians Surg Pak; 2004 Mar; 14(3):183-4. PubMed ID: 15228856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of histiocytic lymphophagocytic panniculitis (Rosai-Dorfman disease) with positive autoantibodies.
    Wang F; Chen X; Wu W; Wang Z; Han J
    J Dtsch Dermatol Ges; 2015 Apr; 13(4):334-6. PubMed ID: 25819246
    [No Abstract]   [Full Text] [Related]  

  • 17. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) treated with 2-chlorodeoxyadenosine.
    Tasso M; Esquembre C; Blanco E; Moscardó C; Niveiro M; Payá A
    Pediatr Blood Cancer; 2006 Oct; 47(5):612-5. PubMed ID: 16302214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosai-Dorfman disease presenting with nasal, nodal and multiple cutaneous involvements responding to a combination of systemic steroid and low-dose thalidomide therapy.
    Kalay Yildizhan I; Sanli H; Akay BN; Erol HM; Kuzu I; Kırmızı A; Cengiz Seval G
    Dermatol Ther; 2021 Jul; 34(4):e14988. PubMed ID: 33993590
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous Rosai-Dorfman disease after Covid 19 vaccination treated with thalidomide.
    Grimaldi M; Perino F; Moretta G; Antonelli F; Paradisi A; Ricci F; Abeni D; Didona B; Fania L
    Dermatol Ther; 2022 Nov; 35(11):e15864. PubMed ID: 36175132
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.
    Nadal M; Kervarrec T; Machet MC; Petrella T; Machet L
    Acta Derm Venereol; 2015 Jul; 95(6):758-9. PubMed ID: 25632986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.